Deltagen’s gene function research is focused on novel genes from gene families with proven drug target success rates in the most important disease areas. These gene families include G protein coupled receptors (GPCRs), proteases, kinases, phosphatases and ion channels thought to be involved in diseases of the cardiovascular, central nervous, gastrointestinal and immune systems, as well as in oncology, metabolism, inflammatory disorders, reproduction and hematology.